Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Larson

Showing results (101-110 of 329) with videos related to

Pageof 33
Sort By:
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Accuracy of FDG-PET in Gastric Cancer. Preliminary ExperienceH W.D. Yeung, H Macapinlac, M Karpeh, et al.
Annals of Biomedical Engineering|August 5, 2000
Enhancing the uptake of chemotherapeutic drugs into tumors using an "artificial lymphatic system"G R DiResta, J Lee, J H Healey, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSHH Tala, R Robbins, J A Fagin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Quantitative bone metastases analysis based on image segmentationY E Erdi, J L Humm, M Imbriaco, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunodetectionS M Larson, C Divgi, A Scott, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 13, 2001
Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literatureR J Robbins, E Voelker, W Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 1999
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical useM R McDevitt, R D Finn, D Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1993
Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemiaG Sgouros, M C Graham, C R Divgi, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
A Coordinate System for Lesion Mapping and Distribution in Progressive Prostate Cancer Using Positron Emission Tomography (PET)N C. Srivastava, Y E. Erdi, C R. Divgi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 1, 1987
Human cerebral glucose metabolism determined by positron emission tomography: a revisitR A Brooks, J Hatazawa, G Di Chiro, et al.
Pageof 33

Showing results (101-110 of 329) with videos related to

Sort By:
Pageof 33
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Accuracy of FDG-PET in Gastric Cancer. Preliminary ExperienceH W.D. Yeung, H Macapinlac, M Karpeh, et al.
Annals of Biomedical Engineering|August 5, 2000
Enhancing the uptake of chemotherapeutic drugs into tumors using an "artificial lymphatic system"G R DiResta, J Lee, J H Healey, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSHH Tala, R Robbins, J A Fagin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Quantitative bone metastases analysis based on image segmentationY E Erdi, J L Humm, M Imbriaco, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunodetectionS M Larson, C Divgi, A Scott, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 13, 2001
Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literatureR J Robbins, E Voelker, W Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 1999
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical useM R McDevitt, R D Finn, D Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1993
Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemiaG Sgouros, M C Graham, C R Divgi, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
A Coordinate System for Lesion Mapping and Distribution in Progressive Prostate Cancer Using Positron Emission Tomography (PET)N C. Srivastava, Y E. Erdi, C R. Divgi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 1, 1987
Human cerebral glucose metabolism determined by positron emission tomography: a revisitR A Brooks, J Hatazawa, G Di Chiro, et al.
Pageof 33